Frost & Sullivan'
Frost & Sullivan congratulates 'China Medical Device Industry Development Report2023)》Official Release
Frost & Sullivan' Frost & Sullivan' Frost & Sullivan Shanghai
With the strong support of the National Medical Products Administration, the 'China Medical Device Industry Development Report ((2023) has been published and distributed by Social Sciences Academic Press. Frost & Sullivan (Frost &Frost & Sullivan, abbreviated as 'Frost & Sullivan', was invited to participate and deliver a special report titled 'Lessons from the Characteristic Development Practices of the Israeli Medical Device Industry for China'. Dr. Wang Xin, Global Partner at Frost & Sullivan and Chairman of the Greater China Region, Founder and Chairman of LeadLeo, was invited to serve as a member of the editorial board.
sinceSince 2017, the China Medical Device Administration Research Association has organized the compilation of the first blue book on medical devices, 'China Medical Device Industry Development Report (2017)'. With the strong support of the National Medical Products Administration, several more blue books have been published successively, each discussing the overall development situation of the industry for that year, as well as specific topics such as policies, industry, and market. The 'China Medical Device Industry Development Report (2023)' (hereinafter referred to as the 'Report') is the seventh installment of the series of medical device blue books and has now been officially released.
Blue Book Introduction:
Comprehensively and systematically present and analyze the current development status of the industry
The 'Report' was developed by the China Medical Device Regulatory Research Association, edited by Wang Baoting and Geng Hongwu, with deputy editors-in-chief Yu Qingming, Jiang Haihong, Li Qiang, and Lu Zhong; thirty-five editorial board members including Tian Ling and Li Hao; and nearly a hundred authors participated in the writing of the report. Based on the current situation of China's medical device industry, it uses detailed materials, data, and charts to discuss issues in policy, industry, market, etc., proposes future development directions for the medical device industry, and provides solutions and policy recommendations.
The Report points out:In 2022, China's medical device industry continued to develop healthily and rapidly. The total number of production and operating enterprises maintained an upward trend. The main business income of medical device manufacturers nationwide was about 1.24 trillion yuan, a growth of approximately 20% compared to the previous year. In the future, China's medical device industry will continue to maintain a relatively fast development pace. The overall quality of medical device products will steadily improve, innovative medical devices will emerge at an accelerated rate, new breakthroughs will be made in the research and development of key core technologies and critical spare parts for some high-end medical devices, and the safety and effectiveness of public use of medical devices will be more strongly guaranteed. China's medical device industry is still in an 'optimal development period'.
The report is divided into six parts: General Report, Policy Section, Industry Section, Region Section, Practice Section, and Reference Section, comprising thirty-five reports. It comprehensively and systematically presents and analyzes the current development status of China's medical device industry, providing references for government supervision, industry research, and corporate market insights, and has significant practical value.
Frost & Sullivan contributors:
Based on years of industry experience, Explore the inspirations from the characteristic development of Israel's medical device industry for China
Frost & Sullivan, drawing on years of industry experience and starting from the current development status of the Israeli medical device industry, elaborates on its development characteristics and experiences, aiming to draw insights for China. They have published a special report titled 'Lessons from the Characteristic Development Practices of the Israeli Medical Device Industry for China'.
According to "Enlightenment from the Characteristic Development of Israel's Medical Device Industry on China," in recent years, Israel's medical device industry has maintained a rapid development trend, with an active financing market, advanced export products, and cutting-edge innovation capabilities. It is committed to using digital technology to achieve breakthroughs in the development and innovation of medical devices. As a world leader in medical device innovation, Israel's excellent academic atmosphere and superior talent resources have built a solid foundation for innovation and entrepreneurship. At the same time, the combination of strong industrial support policies, a complete property rights protection system, diversified capital supply, characteristic incubator models, and scientific research capabilities that combine innovation with practicality has created a mature medical device innovation and entrepreneurship system in Israel. By drawing inspiration from the characteristic development of Israel, it can help enhance China's independent R&D strength in medical devices, promote the high-quality development of China's medical device industry, and stimulate market vitality: on one hand, it can anchor entities such as the government, medical device enterprises, and investment institutions to explore a development environment of joint collaboration, positive interaction, and innovation incentives; on the other hand, it can draw on the operational model of Israel's characteristic incubators to improve the success rate of startups in medical device entrepreneurship.
Dr. Wang Xin stated that Israel is a strong country in technological innovation, and its experience in medical device innovation is of profound significance. As a strategic industry supported by China, the medical device sector is going global and moving towards innovation. Frost & Sullivan hopes to find the focus points for future development within the context of the operation of China's medical device industry by conducting an in-depth analysis of the Israeli medical device industry situation and drawing on the unique experience of Israeli medical devices. This will explore feasible directions for promoting the orderly and healthy development of China's medical device industry.
2023 Frost & Sullivan New Investment Conference
Copyright Notice
Thank you for your attention and support to Frost & Sullivan. If you wish to reprint articles from our WeChat official account, please:
· Leave a message in the original text, indicating the name, introduction, and WeChat official account of the reprinting institution.ID;
· Fill in the author on the editing page"Frost & Sullivan";
· All reposts must not alter, misinterpret, interpret or adapt the original text in any way. Frost & Sullivan reserves the copyright and the right to interpret all original articles. In case of violation, Frost & Sullivan reserves the right to pursue corresponding legal responsibilities according to the law.
About Frost & Sullivan
Global growth consulting firm, Frost & Sullivanfrost &Frost & Sullivan, abbreviated as 'Frost & Sullivan', integrates 62 years of global consulting experience. Over the past 25 years, it has dedicated itself to serving the booming Chinese market with a global perspective. It helps clients accelerate their business growth and achieve benchmark positions in growth, innovation, and leadership within the industry.
Frost & Sullivan specializes in global capital markets and corporate consulting services, providing comprehensive investment and financing as well as various other professional consulting services for enterprises. These include due diligence services, valuation services, assessment services, strategic consulting, management consulting, planning consulting, technical advisory, financial advisory, industry advisory, and more.
Frost & Sullivan's investment and financing business in Greater China has achieved full industry coverage of China's national economy, including a high level of attention to all economic hotspots such as the new economy and new infrastructure. It covers sectors including biomedicine, consumer retail, internet and technology, entertainment media, financial services and fintech, carbon neutrality and environmental protection, machinery manufacturing, energy and power, real estate property, mineral resources, infrastructure, automotive travel, logistics transportation, rail transit, shipping, aerospace, agriculture, forestry, animal husbandry, fishery, industrial materials, construction engineering, education and training.
Since the Frost & Sullivan team began providing investment and financing advisory services to corporate leaders and their management teams, it has helped nearly a thousand companies successfully list on the Hong Kong and overseas stock exchanges. It is a leading enterprise in the field of domestic investment strategy consulting.From 2014 to 2022, Frost & Sullivan has consistently ranked first in the market share for leading Chinese enterprises seeking listings in Hong Kong and overseas as a professional industry advisor. In recent years, Frost & Sullivan reports have also been widely cited in the prospectuses of leading A-share and STAR Market listed companies, primary and secondary market research reports, and other capital market disclosure documents.
For over 62 years, Frost & Sullivan has helped a large number of clients (including Fortune Global 1000 companies, top domestic and international financial institutions, and other leading enterprises) achieve strategic goals by completing tasks including but not limited to due diligence, valuation analysis, and third-party assessments through its nearly 50 offices around the world, utilizing a powerful database and expert library, and applying rich professional knowledge and consulting tools.
